Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality assurance of methylphenidate administration in adults with ADHD
2008-000942-29Phase 3Completed
- Sponsor
- Medice
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate prolonged-release with Placebo (2 arms). Primary endpoint: Change in Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS) score at week 8. Started Nov 2008; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2008-000942-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000942-29.